Company Overview
By using the body’s immune system, Anixa Biosciences is taking multiple approaches to fighting cancer—developing both diagnostics and therapeutics to detect cancer early, when it is most curable, and to treat those afflicted once diagnosed.
Recent News
Anixa Biosciences to Present at the Spartan Capital Securities Second Annual Investor Conference
Anixa Biosciences Announces Issuance of Chinese Patent Covering Breast Cancer Vaccine Technology
Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial
Stock Overview
Symbol
                                    ANIX
                                Exchange
                                    Nasdaq
                                Market Cap
                                    136.61m
                                Last Price
                                    $4.15
                                52-Week Range
                                    $2.07 - $4.98
                                10/31/2025 04:07 PM EDT
Investor Relations
                                                        Mike Catelani
                            President, COO & CFO
                                                                                                                                            T: 408-708-9808
                                                                                                            
